Your browser has javascript turned off or blocked. This will lead to some parts of our website to not work properly or at all. Turn on javascript for best performance.

The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Default user image.

Esa Laurila

Biomedical analyst

Default user image.

Genome-wide meta-analysis identifies novel determinants of circulating serum progranulin

Author

  • Anke Tönjes
  • Markus Scholz
  • Jacqueline Krüger
  • Kerstin Krause
  • Dorit Schleinitz
  • Holger Kirsten
  • Claudia Gebhardt
  • Carola Marzi
  • Harald Grallert
  • Claes Ladenvall
  • Henrike Heyne
  • Esa Laurila
  • Jennifer Kriebel
  • Christa Meisinger
  • Wolfgang Rathmann
  • Christian Gieger
  • Leif Groop
  • Inga Prokopenko
  • Bo Isomaa
  • Frank Beutner
  • Jürgen Kratzsch
  • Antje Fischer-Rosinsky
  • Andreas Pfeiffer
  • Knut Krohn
  • Joachim Spranger
  • Joachim Thiery
  • Matthias Blüher
  • Michael Stumvoll
  • Peter Kovacs

Summary, in English

Progranulin is a secreted protein with important functions in processes including immune and inflammatory response, metabolism and embryonic development. The present study aimed at identification of genetic factors determining progranulin concentrations. We conducted a genome-wide association meta-analysis for serum progranulin in three independent cohorts from Europe: Sorbs (N=848) and KORA (N=1628) from Germany and PPP-Botnia (N=335) from Finland (total N=2811). Single nucleotide polymorphisms (SNPs) associated with progranulin levels were replicated in two additional German cohorts: LIFE-Heart Study (Leipzig; N=967) and Metabolic Syndrome Berlin Potsdam (Berlin cohort; N=833). We measured mRNA expression of genes in peripheral blood mononuclear cells (PBMC) by micro-arrays and performed mRNA expression quantitative trait and expression-progranulin association studies to functionally substantiate identified loci. Finally, we conducted siRNA silencing experiments in vitro to validate potential candidate genes within the associated loci. Heritability of circulating progranulin levels was estimated at 31.8% and 26.1% in the Sorbs and LIFE-Heart cohort, respectively. SNPs at three loci reached study-wide significance (rs660240 in CELSR2-PSRC1-MYBPHL-SORT1, rs4747197 in CDH23- PSAP and rs5848 in GRN) explaining 19.4%/15.0% of the variance and 61%/57% of total heritability in the Sorbs/LIFE-Heart Study. The strongest evidence for association was at rs660240 (P=5.75x10-50), which was also associated with mRNA expression of PSRC1 in PBMC (P=1.51x10-21). Psrc1 knockdown in murine preadipocytes led to a consecutive 30% reduction in progranulin secretion. In conclusion, the present meta-GWAS combined with mRNA expression identified three loci associated with progranulin and supports the role of PSRC1 in the regulation of progranulin secretion.

Department/s

  • Genomics, Diabetes and Endocrinology
  • EXODIAB: Excellence in Diabetes Research in Sweden

Publishing year

2018-02-01

Language

English

Pages

546-558

Publication/Series

Human Molecular Genetics

Volume

27

Issue

3

Document type

Journal article

Publisher

Oxford University Press

Topic

  • Medical Genetics
  • Endocrinology and Diabetes

Status

Published

Research group

  • Genomics, Diabetes and Endocrinology

ISBN/ISSN/Other

  • ISSN: 0964-6906